Selective microglial activation in the rat rotenone model of Parkinson's disease (Q44397650)

2 December 2017

Selective microglial activation in the rat rotenone model of Parkinson's disease (English)

1 reference

2 December 2017

1 reference

1 reference

Todd B Sherer

1

1 reference

2 December 2017

Ranjita Betarbet

series ordinal

2

1 reference

2 December 2017

Jin Ho Kim

series ordinal

3

1 reference

2 December 2017

J Timothy Greenamyre

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

1 reference

2 December 2017

341

1 reference

2 December 2017

87-90

1 reference

2 December 2017

2

1 reference

Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900172-1

7 January 2021

10.1016/S0304-3940(03)00172-1

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pces3i3irjg27gvhqa54vtvuiq

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_pces3i3irjg27gvhqa54vtvuiq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pces3i3irjg27gvhqa54vtvuiq

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/pces3i3irjg27gvhqa54vtvuiq

30 July 2022